A spec sheet for an imported aesthetic device usually has a line about the FDA on it somewhere. The wording varies: registered, listed, cleared, compliant. To a practice deciding what enters the treatment room, those words read as roughly the same reassurance. They are not the same thing, and the gap between them is exactly where a supplier’s claim and a device’s actual file can drift apart.
The distinction is worth thirty minutes before a purchase, because “FDA” on a spec sheet answers a narrower question than most people assume. It tells you what step a device has been through, not whether that step involved anyone at FDA reviewing performance data.
Registration and listing record a company, not a review
Establishment registration and device listing are administrative steps. A manufacturer or distributor registers its facility with FDA and lists the devices it makes or distributes, by product code. That record tells FDA who is selling what, and it tells a buyer that a company has taken that administrative step.
What it does not tell you is that FDA has examined the device’s safety or performance data. Registration and listing are not FDA approval or clearance, and a document that stops at “FDA-registered” has not yet answered the regulatory question a practice actually needs answered.
510(k) clearance and PMA approval sit above that step
Above registration and listing, FDA sorts devices into three classes by risk, and the class determines what has to happen before the device can be marketed. Class I covers the lowest-risk devices and is subject to general controls. Class II typically requires 510(k) premarket notification, where the manufacturer shows the device is substantially equivalent to a device already on the market. Class III, the highest-risk tier, requires premarket approval (PMA), a full review of safety and effectiveness data.
A meaningful number of Class I devices are exempt from 510(k) by rule, because FDA has already determined that the general controls applicable to that product code are enough to manage the risk. The exemption reflects a category-level risk decision by FDA, not a review of the specific unit a manufacturer ships.
Where LHALA JET sits, stated precisely
LHALA JET is listed with FDA as a Class I medical device under product code GFE (model MA-9410A), and that product code is exempt from 510(k) premarket notification. The device performs three functions in sequence: LHAQUA Peel&Fill water peeling, plasma, and Triple JET needle-free delivery, which the manufacturer describes as preparing, purifying and replenishing the skin.
That is the complete, accurate status: Class I, listed, 510(k)-exempt. A practice evaluating any device should be able to state it in exactly that form, without rounding it up or down.
What the listing does not tell you
A Class I, 510(k)-exempt listing is not FDA approval, clearance or endorsement of the device, and it should not be described that way in a treatment room or in marketing to a client. The exemption reflects a category-level risk determination, not a device-specific review of LHALA JET’s own performance data. No premarket submission was reviewed, because none was required for that product code.
Calling this status “FDA-cleared” or “FDA-approved” is not accurate for a listed, exempt device: neither clearance nor approval was required or reviewed for this product code, and the exemption is the reason why. A practice that repeats either term is describing something its own documentation does not support.
What to confirm before the device enters the treatment room
The manufacturer’s instructions for use require that LHALA JET be operated by a trained, qualified professional. What counts as qualified is not spelled out by a specific U.S. credential requirement yet, which means the practical answer comes from your own state’s scope-of-practice rules for aesthetic devices, not from the IFU alone. Confirm that before the device is scheduled into a protocol, not after.
Ask your supplier for the listing record itself, not a summary of it, and check the product code against FDA’s own device classification resources before relying on a one-line spec sheet claim. The U.S. team can send the documentation on file along with pricing and terms for opening a professional account.
What supports what. LHALA JET is listed with FDA as a Class I device, product code GFE, model MA-9410A, and that product code is exempt from 510(k) premarket notification. That listing is not FDA approval, clearance or endorsement of the device. The manufacturer’s instructions for use call for operation by a trained, qualified professional; no specific U.S. credential requirement has been defined for that role.